Eptifibatide recalls
Eptifibatide products have been recalled 2 times, most recently on 4 Mar 2026. The recalling company is usually Eugia US.
Total recalls2since 2024
Last 12 months1reported
Class I00% of total
Ongoing2latest 4 Mar 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 2 100%
Why eptifibatide is recalled
Companies
Product types
By year
Ongoing eptifibatide recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Eptifibatide Injection, 75 mg/ vial recalledEptifibatide | Slate Run Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Eptifibatide injection 20mg/ (2mg/mL) Single-Dose Vial recalledEptifibatide | Eugia US | Potency & Assay | Nationwide |
All eptifibatide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Eptifibatide Injection, 75 mg/ vial recalledEptifibatide | Slate Run Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Eptifibatide injection 20mg/ (2mg/mL) Single-Dose Vial recalledEptifibatide | Eugia US | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.